Alimemazine: appropriate therapeutic agent for solving some difficult problems in the treatment of functional psychotic disorders (clinical cases)

Abstract

Alimemazine is antipsychotic with weak dopaminergic activity. However, it can be useful as additional agent to the basic treatment in some cases. Presented specific clinical
cases demonstrate effectiveness of alimemazine in a number of clinical situations such as: change of therapy from potent dopamine blockers (neuroleptics) to atypical antipsychotic; relief of
the autonomic imbalances; behavioral manifestations of psychopathicJlike disorders in patients with schizophrenia and bipolar affective disorder type 1 in remission. It is assumed that the
inclusion of alimemazine in therapeutic regimen can increase the quality of remission and its duration in this category of patients.